Results for Osteoprotective

Beta-caryophyllene may be used as a therapeutic agent for the prevention and treatment of osteoporosis.

Article Published Date : Nov 30, 2016
Study Type : Animal Study
Additional Links
Substances : Beta-Caryophyllene : CK(2) : AC(1)
Diseases : Osteoporosis : CK(2025) : AC(512)
Pharmacological Actions : Osteoprotective : CK(971) : AC(351)
Additional Keywords : Beta-Caryophyllene, Osteoporosis, Osteoprotective

Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis.

Article Published Date : Sep 30, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Carnosic Acid : CK(121) : AC(82)
Diseases : Bone Diseases : CK(18) : AC(6)
Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(8334), Antioxidants : CK(21528) : AC(8856), NF-kappaB Inhibitor : CK(3536) : AC(2098), Osteoprotective : CK(971) : AC(351)
Additional Keywords : Anti-Inflammatory Agents, Antioxidants : CK(303) : AC(126), Bone Diseases, Carnosic Acid, NF-kappaB Inhibitor, Osteoprotective

Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.

Article Published Date : Apr 30, 2017
Study Type : Human Study
Additional Links
Substances : Yoghurt : CK(1014) : AC(135)
Diseases : Aging : CK(3728) : AC(933), Bone Diseases : CK(18) : AC(6)
Pharmacological Actions : Osteoprotective : CK(971) : AC(351)
Additional Keywords : Aging, Bone Diseases, Osteoprotective, Yoghurt

This study provides a potential treatment candidate for glucocorticoid-induced osteoporosis.

Article Published Date : Aug 24, 2016
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Ginsenosides : CK(1550) : AC(873)
Diseases : Osteoporosis : CK(2025) : AC(512)
Pharmacological Actions : Osteoprotective : CK(971) : AC(351)
Additional Keywords : Dexamethasone : CK(6) : AC(3), Ginsenosides, glucocorticoid, Osteoporosis, Osteoprotective
Problem Substances : Dexamethasone : CK(71) : AC(16)

Using Pueraria mirifica and miroestrol as alternative hormone replacement therapy of E2 might be beneficial.

Article Published Date : Nov 30, 2012
Study Type : Animal Study
Additional Links
Substances : Pueraria mirifica : CK(55) : AC(17)
Diseases : Osteoporosis : CK(2025) : AC(512)
Pharmacological Actions : Osteoprotective : CK(971) : AC(351)
Additional Keywords : Gene Expression Regulation : CK(1141) : AC(501), Osteoporosis, Osteoprotective, Ovariectomy-Induced Changes : CK(299) : AC(126), Pueraria mirifica

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2023 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.